Related references
Note: Only part of the references are listed.The Hippo Pathway in Liver Homeostasis and Pathophysiology
Jordan H. Driskill et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)
MicroRNA-15b in extracellular vesicles from arsenite-treated macrophages promotes the progression of hepatocellular carcinomas by blocking the LATS1-mediated Hippo pathway
Junjie Li et al.
CANCER LETTERS (2021)
Hypoxic bone marrow mesenchymal cell-extracellular vesicles containing miR-328-3p promote lung cancer progression via the NF2-mediated Hippo axis
Xi Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
YAP and endothelin-1 signaling: an emerging alliance in cancer
Piera Tocci et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
Yinghui Hong et al.
FRONTIERS IN ONCOLOGY (2021)
Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5
Xu Lu et al.
JOURNAL OF CANCER (2021)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Nanoparticle-Based Delivery of Tumor Suppressor microRNA for Cancer Therapy
Clodagh P. O'Neill et al.
CELLS (2020)
Periostin Promotes Colorectal Tumorigenesis through Integrin-FAK-Src Pathway-Mediated YAP/TAZ Activation
Handong Ma et al.
CELL REPORTS (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
Epithelial splicing regulatory protein 2-mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis
Jeongeun Hyun et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
Yuchen Liu et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
被撤回的出版物: miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis (Retracted article. See vol. 36, pg. 534, 2021)
Lianshu Piao et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2019)
Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy
Dhruba Kadel et al.
CELL BIOLOGY AND TOXICOLOGY (2019)
miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma
Hao Wu et al.
CELL DEATH & DISEASE (2019)
MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes
Yong He et al.
HEPATOLOGY (2019)
Analysis of the role of the Hippo pathway in cancer
Yanyan Han
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Identification and integrative analysis of microRNAs and mRNAs involved in proliferation and invasion of pressure-treated human liver cancer cell lines
Si Shen et al.
MOLECULAR MEDICINE REPORTS (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
The Role of Stiffness in Cell Reprogramming: A Potential Role for Biomaterials in Inducing Tissue Regeneration
Michele d'Angelo et al.
CELLS (2019)
The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer
Aarti Kolluri et al.
FRONTIERS IN ONCOLOGY (2019)
MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma
Lei Guan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma
Jacopo Gavini et al.
CELL DEATH & DISEASE (2019)
Role of the transcriptional coactivators YAP/TAZ in liver cancer
Shihao Zhang et al.
CURRENT OPINION IN CELL BIOLOGY (2019)
Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine
Ivan M. Moya et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
YAP Promotes VEGFA Expression and Tumor Angiogenesis Though Gli2 in Human Renal Cell Carcinoma
Shan Xu et al.
ARCHIVES OF MEDICAL RESEARCH (2019)
MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma
Timothy A. Dinh et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Hippo Signaling in the Liver - A Long and Ever-Expanding Story
Saumya Manmadhan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Epigenetics of hepatocellular carcinoma
Tan Boon Toh et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Philamer C. Calses et al.
TRENDS IN CANCER (2019)
Current Cancer Epidemiology
Camilla Mattiuzzi et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2019)
CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression
Yuki Makino et al.
CANCER RESEARCH (2018)
YAP/TAZ regulates TGF-beta/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts
Zhaoping Qin et al.
CELL COMMUNICATION AND SIGNALING (2018)
Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer
Sun-Hye Jeong et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
YAP/TAZ upstream signals and downstream responses
Antonio Totaro et al.
NATURE CELL BIOLOGY (2018)
Epigenetics and Epi-miRNAs: Potential markers/therapeutics in leukemia
Fatemeh Memari et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Alternative splicing rewires Hippo signaling pathway in hepatocytes to promote liver regeneration
Sushant Bangru et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
RETRACTED ARTICLE: miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB
Yuanchang Hu et al.
CELL DEATH & DISEASE (2018)
miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
Minjiang Chen et al.
EBIOMEDICINE (2018)
YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Satoshi Noguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2
Li-Li Han et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Yumeng Wang et al.
CELL REPORTS (2018)
被撤回的出版物: miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB (Retracted article. See vol. 14, 2023)
Yuanchang Hu et al.
CELL DEATH & DISEASE (2018)
miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression
Li Li Han et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis
Sachin H. Patel et al.
GASTROENTEROLOGY (2017)
Hepatostat: Liver Regeneration and Normal Liver Tissue Maintenance
George K. Michalopoulos
HEPATOLOGY (2017)
Circulating miRNAs and miRNA shuttles as biomarkers: Perspective trajectories of healthy and unhealthy aging
Fabiola Olivieri et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2017)
Molecular alterations of the NF2 gene in hepatocellular carcinoma and intrahepatic
Ning Zhang et al.
ONCOLOGY REPORTS (2017)
CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway
Dawoon E. Jung et al.
SCIENTIFIC REPORTS (2017)
MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma
Lina Cheng et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells
Beibei Bie et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity
Toshiro Moroishi et al.
CELL (2016)
Effect of co-transfection of miR-520c-3p and miR-132 on proliferation and apoptosis of hepatocellular carcinoma Huh7
Chang-Jiang Lei et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2016)
MicroRNA-186 targets Yes-associated protein 1 to inhibit Hippo signaling and tumorigenesis in hepatocellular carcinoma
Tingyan Ruan et al.
ONCOLOGY LETTERS (2016)
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
Yinghong Pan et al.
ONCOTARGET (2016)
microRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma
Lei Zhang et al.
FEBS OPEN BIO (2016)
YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma
Michael J. LaQuaglia et al.
SCIENTIFIC REPORTS (2016)
Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison
Sijia Shen et al.
SCIENTIFIC REPORTS (2016)
MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma
C. Nelson Hayes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis
Yuhang Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy
Guofeng Cheng
ADVANCED DRUG DELIVERY REVIEWS (2015)
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
T. Higashi et al.
BRITISH JOURNAL OF CANCER (2015)
Hsa-miR-132 inhibits proliferation of hepatic carcinoma cells by targeting YAP
Chang-Jiang Lei et al.
CELL BIOCHEMISTRY AND FUNCTION (2015)
A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis
Shuying Shen et al.
CELL RESEARCH (2015)
MiRNA-based therapeutic intervention of cancer
Srivatsava Naidu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
MicroRNA-125b suppresses the migration and invasion of hepatocellular carcinoma cells by targeting transcriptional coactivator with PDZ-binding motif
Jipeng Li et al.
ONCOLOGY LETTERS (2015)
MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis
Song Hea et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma
Peng Liu et al.
ONCOTARGET (2015)
A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions
Thomas Bertero et al.
SCIENTIFIC REPORTS (2015)
Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers
Yusuke Oku et al.
FEBS OPEN BIO (2015)
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Kazuyoshi Shiga et al.
CANCERS (2015)
The Hippo signaling pathway in liver regeneration and tumorigenesis
Lixin Hong et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2015)
Hippo-YAP signaling pathway: A new paradigm for cancer therapy
Yanlei Ma et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
MIR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3′UTR
Yue Wang et al.
ACTA PHARMACOLOGICA SINICA (2014)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
Yes-Associated Protein Expression is a Predictive Marker for Recurrence of Hepatocellular Carcinoma after Liver Transplantation
Hua Li et al.
DIGESTIVE SURGERY (2014)
The Hippo signaling pathway in stem cell biology and cancer
Jung-Soon Mo et al.
EMBO REPORTS (2014)
YAP activation is an early event and a potential therapeutic target in liver cancer development
Andrea Perra et al.
JOURNAL OF HEPATOLOGY (2014)
The Hippo pathway: regulators and regulations
Fa-Xing Yu et al.
GENES & DEVELOPMENT (2013)
MicroRNAs: New Tools for Diagnosis, Prognosis, and Therapy in Hepatocellular Carcinoma?
Silvia Giordano et al.
HEPATOLOGY (2013)
Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma
Xinying Huo et al.
ONCOLOGY REPORTS (2013)
The Hippo-Yes Association Protein Pathway in Liver Cancer
Lu Jie et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Role of Substratum Stiffness in Modulating Genes Associated with Extracellular Matrix and Mechanotransducers YAP and TAZ
Vijay Krishna Raghunathan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Fibrosis-dependent mechanisms of hepatocarcinogenesis
David Y. Zhang et al.
HEPATOLOGY (2012)
Yes-Associated Protein 1 Is Activated and Functions as an Oncogene in Meningiomas
Gilson S. Baia et al.
MOLECULAR CANCER RESEARCH (2012)
Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP
L. Angus et al.
ONCOGENE (2012)
miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w
Xiaoyan Yang et al.
ONCOLOGY REPORTS (2012)
The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
Wanjin Hong et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study
Angela M. Liu et al.
BMJ OPEN (2012)
Yes-Associated Protein Regulation of Adaptive Liver Enlargement and Hepatocellular Carcinoma Development in Mice
Marta A. Kowalik et al.
HEPATOLOGY (2011)
KIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases
Ling Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Hedgehog signaling in the liver
Alessia Omenetti et al.
JOURNAL OF HEPATOLOGY (2011)
MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties
Angela M. Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Nobuyoshi Kosaka et al.
CANCER SCIENCE (2010)
The MicroRNA Spectrum in 12 Body Fluids
Jessica A. Weber et al.
CLINICAL CHEMISTRY (2010)
The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
Nailing Zhang et al.
DEVELOPMENTAL CELL (2010)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Merlin in organ size control and tumorigenesis: Hippo versus EGFR?
Chunling Yi et al.
GENES & DEVELOPMENT (2010)
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Hai Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MicroRNAs: Control and Loss of Control in Human Physiology and Disease
Min Li et al.
WORLD JOURNAL OF SURGERY (2009)
The emerging role of the Hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals
Qi Zeng et al.
CANCER CELL (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation
Maria Praskova et al.
CURRENT BIOLOGY (2008)
Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila
Xiaomu Wei et al.
EMBO JOURNAL (2007)
The Drosophila RASSF homolog antagonizes the hippo pathway
Cedric Polesello et al.
CURRENT BIOLOGY (2006)
Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway
F. Christian Bennett et al.
CURRENT BIOLOGY (2006)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Share Paper
